Loading your page…
Each register with its number of medicines and a few of them.
Health Canada · 4 medicines
CBG-MEB · 4 medicines
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
AEMPS · 3 medicines
MS · 3 medicines · Historical list
SFDA · 3 medicines · Historical list
HSA · 2 medicines
FDA · 2 medicines
Anvisa · 1 medicine
EMA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
25 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Benlysta | United States | 120MG, 200MG/ML, 400MG | injectable | Marketed | Human Genome Sciences INC. |
| Benlysta | United States | 200MG/ML | Injection | Marketed | GlaxoSmithKline LLC |
| Benlysta | European Union | Authorised | GlaxoSmithKline Trading Services Limited | ||
| Benlysta | Italy | Soluzione iniettabile | Authorised | Glaxosmithkline (Ireland) Limited | |
| Benlysta 200 MG Solucion Inyectable en Pluma Precargada | Spain | 200 mg | solución inyectable en pluma precargada | Marketed | Glaxosmithkline (Ireland) Limited |
| BENLYSTA 120 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | Spain | 120 mg | polvo para concentrado para solución para perfusión | Marketed | Glaxosmithkline (Ireland) Limited |
| BENLYSTA 400 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | Spain | 400 mg | polvo para concentrado para solución para perfusión | Marketed | Glaxosmithkline (Ireland) Limited |
| Benlysta | Canada | 120 MG / VIAL | Powder For Solution | Marketed | Glaxosmithkline INC |
| Benlysta | Canada | 400 MG / VIAL | Powder For Solution | Marketed | Glaxosmithkline INC |
| Benlysta | Canada | 200 MG / 1 ML | Solution | Marketed | Glaxosmithkline INC |
| Benlysta 120 mg, Poeder voor oplossing voor infusie | Netherlands | Poeder voor oplossing voor infusie | Authorised | GlaxoSmithKline (Ireland) Ltd. | |
| Benlysta 400 mg, Poeder voor oplossing voor infusie | Netherlands | Poeder voor oplossing voor infusie | Authorised | GlaxoSmithKline (Ireland) Ltd. | |
| Benlysta 200 mg oplossing voor injectie in voorgevulde pen | Netherlands | Oplossing voor injectie | Authorised | GlaxoSmithKline (Ireland) Ltd. | |
| Benlysta 200 mg oplossing voor injectie in voorgevulde spuit | Netherlands | Oplossing voor injectie | Authorised | GlaxoSmithKline (Ireland) Ltd. | |
| Benlysta | Brazil | Authorised | Glaxosmithkline Brasil Ltda | ||
| Benlysta | Croatia | Marketed | |||
| Benlysta Powder for Solution for Infusion 120mg | Singapore | 120mg/vial | injection, powder, lyophilized, for solution | Authorised | Glaxosmithkline Pte LTD |
| Benlysta Powder for Solution for Infusion 400mg | Singapore | 400mg/vial | injection, powder, lyophilized, for solution | Authorised | Glaxosmithkline Pte LTD |
| Benlysta | Saudi Arabia | Authorised | Glaxo Operations UK Ltd | ||
| Benlysta 120MG Powder for Solution for Infusion | Saudi Arabia | Authorised | Hospira | ||
| Benlysta 400MG Powder for Solution for Infusion | Saudi Arabia | Authorised | Hospira | ||
| Benlysta | Romania | 120 mg | pulb. pt. conc. pt. sol. perf. | Status unknown | Glaxosmithkline (Ireland) Limited |
| Benlysta | Canada | 200 MG / 1 ML | Solution | Cancelled | Glaxosmithkline INC |
| BENLYSTA 120mg | Romania | 120mg | pulb. pt. conc. pt. sol. perf. | Status unknown | Glaxo Group Limited |
| BENLYSTA 400mg | Romania | 400mg | pulb. pt. conc. pt. sol. perf. | Status unknown | Glaxo Group Limited |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, MS and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
